HEADER TRANSFERASE/TRANSFERASE INHIBITOR 10-AUG-10 3OCT
TITLE CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R IN COMPLEX
TITLE 2 WITH DASATINIB
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: BRUTON TYROSINE KINASE, AGAMMAGLOBULINAEMIA TYROSINE KINASE,
COMPND 5 ATK, B-CELL PROGENITOR KINASE, BPK;
COMPND 6 EC: 2.7.10.2;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BTK, AGMX1, ATK, BPK;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBACGUS
KEYWDS TYROSINE KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR
KEYWDS 2 COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR D.R.DAVIES,B.L.STAKER
REVDAT 3 06-SEP-23 3OCT 1 REMARK SEQADV
REVDAT 2 17-NOV-10 3OCT 1 HEADER
REVDAT 1 03-NOV-10 3OCT 0
JRNL AUTH J.A.DI PAOLO,T.HUANG,M.BALAZS,J.BARBOSA,K.H.BARCK,
JRNL AUTH 2 R.A.D.CARANO,J.DARROW,D.R.DAVIES,L.E.DEFORGE,G.DENNIS JR.,
JRNL AUTH 3 L.DIEHL,R.FERRANDO
JRNL TITL A NOVEL, SPECIFIC BTK INHIBITOR ANTAGONIZES BCR AND
JRNL TITL 2 FC[GAMMA]R SIGNALING AND SUPPRESSES INFLAMMATORY ARTHRITIS
JRNL REF TO BE PUBLISHED
JRNL REFN
REMARK 2
REMARK 2 RESOLUTION. 1.95 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.5.0109
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.55
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 18379
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.199
REMARK 3 R VALUE (WORKING SET) : 0.196
REMARK 3 FREE R VALUE : 0.251
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300
REMARK 3 FREE R VALUE TEST SET COUNT : 973
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1333
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.44
REMARK 3 BIN R VALUE (WORKING SET) : 0.2700
REMARK 3 BIN FREE R VALUE SET COUNT : 68
REMARK 3 BIN FREE R VALUE : 0.3300
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1992
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 33
REMARK 3 SOLVENT ATOMS : 101
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.92
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 2.40000
REMARK 3 B22 (A**2) : -0.99000
REMARK 3 B33 (A**2) : 0.79000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 2.86000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.198
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.181
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.689
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2093 ; 0.015 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2825 ; 1.543 ; 1.980
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 242 ; 6.443 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 96 ;34.501 ;23.750
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 374 ;14.960 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.764 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 296 ; 0.102 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1582 ; 0.006 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1222 ; 0.742 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1968 ; 1.401 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 871 ; 2.368 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 856 ; 3.649 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 394 A 475
REMARK 3 ORIGIN FOR THE GROUP (A): 18.4965 6.5333 14.9024
REMARK 3 T TENSOR
REMARK 3 T11: 0.0281 T22: 0.0453
REMARK 3 T33: 0.0758 T12: -0.0111
REMARK 3 T13: -0.0033 T23: -0.0124
REMARK 3 L TENSOR
REMARK 3 L11: 3.8068 L22: 1.6741
REMARK 3 L33: 2.2081 L12: 0.5350
REMARK 3 L13: 0.4949 L23: 0.3311
REMARK 3 S TENSOR
REMARK 3 S11: 0.1452 S12: 0.0690 S13: -0.0727
REMARK 3 S21: 0.0699 S22: 0.0125 S23: -0.2960
REMARK 3 S31: 0.0492 S32: 0.2452 S33: -0.1577
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 476 A 656
REMARK 3 ORIGIN FOR THE GROUP (A): -6.7465 -1.0733 17.5630
REMARK 3 T TENSOR
REMARK 3 T11: 0.0366 T22: 0.0164
REMARK 3 T33: 0.0156 T12: 0.0093
REMARK 3 T13: 0.0005 T23: 0.0078
REMARK 3 L TENSOR
REMARK 3 L11: 1.0483 L22: 0.9324
REMARK 3 L33: 1.2483 L12: 0.3352
REMARK 3 L13: -0.1945 L23: 0.2557
REMARK 3 S TENSOR
REMARK 3 S11: -0.0163 S12: 0.0879 S13: 0.0704
REMARK 3 S21: 0.0302 S22: -0.0168 S23: 0.0632
REMARK 3 S31: 0.0624 S32: -0.0102 S33: 0.0331
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE
REMARK 4
REMARK 4 3OCT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-10.
REMARK 100 THE DEPOSITION ID IS D_1000060953.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-FEB-08
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 5.40
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 24-ID-C
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL
REMARK 200 WAVELENGTH OR RANGE (A) : 0.98
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22490
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760
REMARK 200 RESOLUTION RANGE LOW (A) : 59.550
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 81.5
REMARK 200 DATA REDUNDANCY : 3.200
REMARK 200 R MERGE (I) : 0.07700
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82
REMARK 200 COMPLETENESS FOR SHELL (%) : 51.0
REMARK 200 DATA REDUNDANCY IN SHELL : 2.20
REMARK 200 R MERGE FOR SHELL (I) : 0.36400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: 3OCS
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.58
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, PH 5.4, 20% PEG 3500, 200
REMARK 280 MM NACL, 3% POLYPROPYLENE GLYCOL P 400, VAPOR DIFFUSION,
REMARK 280 TEMPERATURE 289K, VAPOR DIFFUSION, SITTING DROP, PH 5.40
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.47200
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 392
REMARK 465 GLY A 393
REMARK 465 GLY A 409
REMARK 465 THR A 410
REMARK 465 GLU A 434
REMARK 465 GLY A 435
REMARK 465 SER A 436
REMARK 465 TYR A 545
REMARK 465 VAL A 546
REMARK 465 LEU A 547
REMARK 465 ASP A 548
REMARK 465 ASP A 549
REMARK 465 GLU A 550
REMARK 465 TYR A 551
REMARK 465 THR A 552
REMARK 465 SER A 553
REMARK 465 SER A 554
REMARK 465 ARG A 555
REMARK 465 GLY A 556
REMARK 465 SER A 557
REMARK 465 LYS A 558
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 407 CG CD OE1 OE2
REMARK 470 LYS A 433 CG CD CE NZ
REMARK 470 LYS A 466 CG CD CE NZ
REMARK 470 GLN A 467 CG CD OE1 NE2
REMARK 470 ARG A 520 CG CD NE CZ NH1 NH2
REMARK 470 PHE A 559 CG CD1 CD2 CE1 CE2 CZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 GLU A 513 CB GLU A 513 CG 0.121
REMARK 500 GLU A 513 CG GLU A 513 CD 0.113
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 520 -13.36 67.57
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 A 663
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3OCS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH
REMARK 900 INHIBITOR CGI1746
DBREF 3OCT A 393 656 UNP Q06187 BTK_HUMAN 393 656
SEQADV 3OCT GLY A 392 UNP Q06187 EXPRESSION TAG
SEQADV 3OCT ARG A 555 UNP Q06187 VAL 555 ENGINEERED MUTATION
SEQRES 1 A 265 GLY GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE
SEQRES 2 A 265 LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS
SEQRES 3 A 265 TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS
SEQRES 4 A 265 MET ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE
SEQRES 5 A 265 GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS
SEQRES 6 A 265 LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO
SEQRES 7 A 265 ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU
SEQRES 8 A 265 LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR
SEQRES 9 A 265 GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA
SEQRES 10 A 265 MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP
SEQRES 11 A 265 LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL
SEQRES 12 A 265 VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU
SEQRES 13 A 265 ASP ASP GLU TYR THR SER SER ARG GLY SER LYS PHE PRO
SEQRES 14 A 265 VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS
SEQRES 15 A 265 PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU
SEQRES 16 A 265 MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU
SEQRES 17 A 265 ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN
SEQRES 18 A 265 GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS
SEQRES 19 A 265 VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA
SEQRES 20 A 265 ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE
SEQRES 21 A 265 LEU ASP VAL MET ASP
HET 1N1 A 663 41
HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)
HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-
HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE
HETSYN 1N1 DASATINIB
FORMUL 2 1N1 C22 H26 CL N7 O2 S
FORMUL 3 HOH *101(H2 O)
HELIX 1 1 ASP A 398 LYS A 400 5 3
HELIX 2 2 SER A 438 ASN A 451 1 14
HELIX 3 3 CYS A 481 MET A 489 1 9
HELIX 4 4 GLN A 494 LYS A 515 1 22
HELIX 5 5 ALA A 523 ARG A 525 5 3
HELIX 6 6 PRO A 560 SER A 564 5 5
HELIX 7 7 PRO A 565 SER A 572 1 8
HELIX 8 8 SER A 575 SER A 592 1 18
HELIX 9 9 THR A 602 GLN A 612 1 11
HELIX 10 10 SER A 623 CYS A 633 1 11
HELIX 11 11 LYS A 637 ARG A 641 5 5
HELIX 12 12 THR A 643 ASP A 656 1 14
SHEET 1 A 5 LEU A 402 GLU A 407 0
SHEET 2 A 5 VAL A 415 TRP A 421 -1 O TYR A 418 N LYS A 406
SHEET 3 A 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417
SHEET 4 A 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430
SHEET 5 A 5 LEU A 460 CYS A 464 -1 N TYR A 461 O ILE A 473
SHEET 1 B 2 CYS A 527 VAL A 529 0
SHEET 2 B 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528
CISPEP 1 ARG A 468 PRO A 469 0 4.41
SITE 1 AC1 15 ALA A 428 LYS A 430 MET A 449 ILE A 472
SITE 2 AC1 15 THR A 474 GLU A 475 TYR A 476 MET A 477
SITE 3 AC1 15 ALA A 478 ASN A 479 GLY A 480 GLU A 488
SITE 4 AC1 15 LEU A 528 SER A 538 PHE A 540
CRYST1 54.101 42.944 64.542 90.00 112.58 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018484 0.000000 0.007687 0.00000
SCALE2 0.000000 0.023286 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016780 0.00000